Seqera Labs - About the company
Seqera Labs is a series A company based in Barcelona (Spain), founded in 2018 by Evan Floden and Paolo Di Tommaso. It operates as a Provider of a bioinformatics platform for scientific data analysis and workflow management. Seqera Labs has raised $27.2M in funding from investors like Speedinvest, Talis Capital and Addition Capital. The company has 34 active competitors, including 4 funded and 4 that have exited. Its top competitors include companies like Benchling, Curoverse and PubHive.
Company Details
Provider of a bioinformatics platform for scientific data analysis and workflow management. The platform centralizes data, streamlines pipelines, and manages infrastructure within a secure environment. It integrates with existing on-premises systems and cloud platforms, maintaining control over data residency. The platform offers a unified environment for high-throughput, cost-effective computation, suitable for genomics and AI-based drug discovery. It facilitates collaboration between teams through an intuitive interface and secure APIs, ensuring reproducible workflows and auditability.
- Website
- seqera.io
- Email ID
- *****@seqera.io
Key Metrics
Founded Year
2018
Location
Barcelona, Spain
Stage
Series A
Total Funding
$27.2M in 3 rounds
Latest Funding Round
Investors
Ranked
2nd among 34 active competitors
Employee Count
121 as on May 31, 2026
Sign up to download Seqera Labs' company profile
Seqera Labs's funding and investors
Seqera Labs has raised a total funding of $27.2M over 3 rounds. Its first funding round was on Sep 07, 2021. Its latest funding round was a Series A round on Oct 25, 2022 for $*****. 5 investors participated in its latest round. Seqera Labs has 6 institutional investors and 2 angel investors.
Here is the list of recent funding rounds of Seqera Labs:
Date of Funding | Funding Amount | Round Name | Post-Money Valuation | Revenue Multiple | Lead Investors | Other Investors |
|---|---|---|---|---|---|---|
Oct 25, 2022 | 8815542 | Series A | 4832906 | 3839343 | 8678152 | 1524417 |
Sep 07, 2021 | 4108857 | Grant (prize money) | 6473295 | 3494756 | 1719435 | |
Sep 07, 2021 | 7260563 | Seed | 6454514 | 7660009 |
View details of Seqera Labs's funding rounds and investors
Seqera Labs' founders and board of directors
Founder? Claim ProfileThe founders of Seqera Labs are Evan Floden and Paolo Di Tommaso. Evan Floden is the CEO of Seqera Labs.
Here are the details of Seqera Labs' key team members:
- Evan Floden: Co-Founder & CEO of Seqera Labs. Contact Info: 1 email address
- Paolo Di Tommaso: Co-Founder of Seqera Labs. Contact Info: 1 email address
View details of Seqera Labs's Founder profiles and Board Members
Seqera Labs' employee count trend
Seqera Labs has 121 employees as of May 26. Here is Seqera Labs's employee count trend over the years:
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
Seqera Labs's Competitors and alternates
Top competitors of Seqera Labs include Benchling, Curoverse and PubHive. Here is the list of Top 10 competitors of Seqera Labs, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st | Benchling 2012, San Francisco (United States), Series F | Provider of a cloud-based bioinformatics platform for biotech research | $412M | 73/100 | |
2nd | Seqera Labs 2018, Barcelona (Spain), Series A | Provider of a bioinformatics platform for scientific data analysis and workflow management | $27.2M | 44/100 | |
3rd | Curoverse 2010, Boston (United States), Acquired | Biomedical data solutions empowering precision medicine through open source technology | $1.7M | 43/100 | |
4th | PubHive 2020, London (United Kingdom), Unfunded | Provider of a cloud-based solution for scientific literature workflow management | - | - | 41/100 |
5th | AI VIVO 2017, Cambridge (United Kingdom), Funding Raised | AI enabled platform for data analytics and drug development | - | 39/100 | |
6th | Vyasa 2016, Newburyport (United States), Acquired | Provider of deep learning platform for life sciences market research | - | 36/100 | |
7th | Infonetica 2003, Esher (United Kingdom), Acquired | Provider of software solution for clinical research | - | 36/100 | |
8th | Online platform to find research partners | - | 34/100 | ||
9th | Linum Labs 2016, Cape Town (South Africa), Unfunded | Blockchain-based solutions for multi-industry applications | - | - | 33/100 |
10th | AI-powered knowledge management platform | - | - | 32/100 |
Looking for more details on Seqera Labs's competitors? Click here to see the top ones
Seqera Labs's Investments and acquisitions
Seqera Labs has made no investments or acquisitions yet.
News related to Seqera Labs
•
Seqera Acquires Tinybio to Democratize Access to AI-Powered BioinformaticsHIT Consultant•Aug 07, 2024•Seqera Labs, Tinybio
•
Seqera launches Seqera containers to enable reproducibility and innovation in bioinformaticsBusiness Wire•May 24, 2024•Seqera Labs
•
•
Genomics England partners with Seqera Labs to improve NHS cancer careOutsourcing-Pharma•May 29, 2023•Seqera Labs, Genomics England
•
Seqera Labs Closes €22M Series A Investment RoundGenomeWeb•Oct 25, 2022•The Chan Zuckerberg Initiative, Seqera Labs, Talis Capital, Speedinvest and 3 others
•
Seqera Labs grabs $5.5M to help sequence COVID-19 variants and other complex data problemsTechCrunch+•Sep 07, 2021•Seqera Labs, Talis Capital, Speedinvest, BoxOne Ventures and 1 other
Are you a Founder ?
FAQs about Seqera Labs
Explore our recently published companies
- Backchat Media - Tauranga based, 2014 founded, Acquired company
- Growzle - London based, 2025 founded, Unfunded company
- X-AVA - United States based, 2021 founded, Unfunded company
- Uresco Construction Materials - Kent based, 1979 founded, Unfunded company
- Aaa Flat Rate Moving - Sarasota based, 1980 founded, Unfunded company
- Walzak Marketing - Milwaukee based, 1980 founded, Unfunded company